Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by davewhoon Aug 18, 2021 2:35pm
151 Views
Post# 33724565

RE:RE:10 year chart says it all

RE:RE:10 year chart says it allI have asked IR to confirm the 100k number James mentioned clearly on the CC. I listened to it 5x now. No answer back yet from IR. James also said Treat traffic is up 1000% since the start of the year and Avrt traffic up 55% in the last 30 days. Care is the one running this program those numbers must have come from them. Do the math those are some pretty big rev numbers especially if patients want Aristotle along with the rest of the program. I agree with Boomer those of us who believe are here for more than just the money. We want to see Stage accomplish what they started 20 years ago. Obviously its not fast enough for some investors but others will look at the quality of the Care Management team and ask themselves why are they here if things are not looking good? They have put it ALL on the line just to be part of Aristotle's future and to date show no signs of getting cold feet despite what the SP and covid rev are doing. Sure makes me wonder. 
<< Previous
Bullboard Posts
Next >>